DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Diabetes Devices Market Analysis By Device Type, Delivery Type And Segment Forecasts To 2024" report to their offering.
The global diabetes devices market is expected to reach USD 35.5 billion by the year 2024, according to this report.
Major drivers of the market include the growing number of diabetic patients owing to the sedentary lifestyles and unhealthy food habits. The growing demand for the advanced and minimally invasive, diagnostic as well as monitoring devices is expected to propel the market growth during the forecast period.
The rising awareness with regard to the technologically advanced monitoring tools, such as the continuous glucose monitor, is a crucial factor expected to spur the growth of the market. The demand for affordable monitoring devices in the developed as well as the less-developed countries is expected to propel the market growth of products, such as glucose test strips.
The existence of relatively smooth product approval procedures in most of the developed countries including the U.S and European countries are expected to boost the insulin devices market. The rising popularity of the compact, easy to carry monitoring devices, and the introduction of minimally invasive, highly efficient devices is expected to drive the market growth at a lucrative rate. However, the disparity in the reimbursement policies is primarily challenging the overall growth of this market.
Companies Profiled:
- Abbott laboratories Inc.
- F. Hoffmann-La Roche AG
- Johnson and Johnson
- Bayer HealthCare AG
- Becton, Dickinson and Company
- Medtronic Inc.
- Novo Nordisk A/S
-
Sanofi
Key Topics Covered:
1 Methodology and Scope
2 Executive Summary
3 Diabetes Devices Industry Outlook
4 Diabetes Devices Product Outlook
5 Diabetes Devices Market Regional Outlook
6 Competitive Landscape
For more information visit http://www.researchandmarkets.com/research/h4hlqr/diabetes_devices
